Ascletis Pharma Inc. (HKG:1672)
Hong Kong · Delayed Price · Currency is HKD 11.54
+0.25 (2.21%)
Jul 3, 2026, 4:08 PM HKT
Ascletis Pharma Market Cap
Ascletis Pharma has a market cap or net worth of 12.25 billion as of July 2, 2026. Its market cap has increased by 50.90% in one year.
Market Cap
12.25B
Enterprise Value
10.14B
Revenue
2.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.54
Market Cap Chart
Since August 1, 2018, Ascletis Pharma's market cap has decreased from 15.69B to 12.25B, a decrease of -21.93%. That is a compound annual growth rate of -3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 12.25B | 8.96% |
| Dec 31, 2025 | 11.24B | 287.10% |
| Dec 31, 2024 | 2.90B | 90.74% |
| Dec 29, 2023 | 1.52B | -70.46% |
| Dec 30, 2022 | 5.15B | 44.13% |
| Dec 31, 2021 | 3.58B | 13.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 16.85B |
| Metis TechBio | 16.05B |
| Ascentage Pharma Group International | 12.85B |
| Shaanxi Micot Pharmaceutical Technology | 11.93B |
| GenFleet Therapeutics (Shanghai) | 11.14B |
| TenNor Therapeutics (Suzhou) | 10.35B |
| Nanjing Leads Biolabs | 10.15B |
| Everest Medicines | 9.77B |